Why the study?
Desmoplakin mutations frequently cause arrhythmogenic cardiomyopathy presenting with recurrent myocarditis-like hot phases that contribute to myocardial injury and increased arrhythmic risk, requiring disease-specific risk stratification and targeted management strategies.
Case Report (n=1)
No
This case highlights that emotional stress can trigger recurrent inflammatory 'hot phases' in desmoplakin-associated arrhythmogenic cardiomyopathy, and suggests that combining primary prevention ICD implantation with beta-blocker optimization (propranolol) and low-dose SSRI therapy may prevent recurrent flares and arrhythmias.
Answers are grounded in this paper and cite their sources.
Recognizes emotional stress as a potential trigger in DSP cardiomyopathy; leaves open prospective validation of hot-phase risk management.
Background Desmoplakin (DSP) mutations are a common cause of arrhythmogenic cardiomyopathy (ACM), frequently presenting with recurrent myocarditis-like ‘hot phases’ that contribute to myocardial injury and increased arrhythmic risk. Case Summary A 40-year-old woman presented with acute chest pain and marked troponin elevation following emotional stress. Her history was notable for recurrent stress-related myocarditis episodes and a diagnosis of biventricular arrhythmogenic cardiomyopathy due to a pathogenic DSP mutation. Cardiac magnetic resonance demonstrated diffuse myocardial oedema and a characteristic circumferential subepicardial ring-like pattern of late gadolinium enhancement, consistent with an active hot phase. Given the high-risk pathogenic DSP mutation with multiple high-risk features, including documented non-sustained ventricular tachycardia, frequent ventricular ectopy, and mild left ventricular disfunction (resulting in a calculated 5-year arrhythmic risk of 12% according to the novel DSP risk score)—and the presence of frequent hot phases recurrences and high burden of late gadolinium enhancement—a primary prevention implantable cardioverter–defibrillator was implanted after clinical stabilization. Medical therapy was optimized with β-blocker up-titration and low-dose selective serotonin reuptake inhibitor therapy targeting recurrent stress-related triggers. At follow-up, the patient reported sustained clinical well-being with no recurrence of hot phases or arrhythmic events. Conclusion This case exemplifies DSP-related arrhythmogenic cardiomyopathy marked by recurrent, stress-triggered ‘hot phases,’ highlighting the pivotal interplay between inflammation and arrhythmic risk, and underscoring the need for refined, disease-specific risk stratification and targeted management strategies.
No takes yet. Share an insight, caveat, or question.
Caputo et al. (2026) conducted a case report in Desmoplakin-associated biventricular arrhythmogenic cardiomyopathy with recurrent emotional stress-induced myocarditis-like hot phases (n=1). Primary prevention transvenous implantable cardioverter-defibrillator (ICD) implantation, beta-blocker optimization (propranolol), and low-dose selective serotonin reuptake inhibitor (SSRI) therapy was evaluated on Recurrence of inflammatory 'hot phases' or sustained ventricular arrhythmias.
Synapse has enriched 10 related papers. Consider them for comparative context: